Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Ajai Chari, MD, Talks Talquetamab for Relapsed/Refractory MM

 

In this video, Dr Chari discusses the findings of a phase 1 trial examining the use of talquetamab in heavily pretreated patients with relapsed or refractory multiple myeloma (MM).

Advertisement

Advertisement

Advertisement

Advertisement